PDS PLATE UNKNOWN PRODUCT

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a literature report with the FDA on 2018-04-05 for PDS PLATE UNKNOWN PRODUCT manufactured by Ethicon Inc..

Event Text Entries

[104533567] (b)(4). This report is related to a journal article, therefore no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided. Additional information was requested and the following was obtained: does the surgeon believe that ethicon products involved caused and/or contributed to the post-operative complications described in the article? Does the surgeon believe there was any deficiency with the ethicon products used in this procedure? The recurrent septal deviation is not a complication from the pds plate but a risk of any septal surgery. There was a septal infection in a (b)(6) yo patient 2 months after placement of pds plate but when we drained the abscess i did not see pds plate remaining. Citation: laryngoscope. 2017; 127. Doi: 10. 1002/lary. 26592 - [(b)(4)-fuller 2017 (1). Pdf].
Patient Sequence No: 1, Text Type: N, H10


[104533568] It was reported via journal article:? Title: polydioxanone plates are safe and effective for l-strut support in functional septorhinoplasty?. Authors: jennifer c. Fuller, md, patricia a. Levesque, bs, robin w. Lindsay, md. Citation: laryngoscope. 2017; 127. Doi: 10. 1002/lary. 26592. The objectives of this retrospective analysis of a prospective cohort was to evaluate the safety, efficacy, and result stability of polydioxanone (pds) plate use for l-strut stabilization. A total of 88 patients (45 male and 43 female; age range: 8 to 72 years old) with fracture and/or severe deviation of the l-strut underwent functional septorhinoplasty (fsrp) for nasal airway obstruction (nao) for which the pds plate was used for rigid support and were included in the study. A standard open fsrp approach was used for all cases, but one case, in which a 0. 15 mm pds perforated plate was used. In the rest of the cases, a 0. 25 mm non-perforated pds plate were used. The plate was typically cut into an l shape measuring 2 to 3. 5cm dorsally, 1 to 2 cm caudally, and 1 cm in width. The plates were placed along one side of the septum and sutured into place using pds 5-0 suture. The pds plate was used when a septal fracture violated the 1- to 1. 5-cm cartilaginous l-strut and the fracture was not adequately braced with a spreader graft, when there was a persistent concavity or convexity of the dorsal or caudal portion of the l-strut not completely resolved with standard techniques (swinging door, spreader grafts, extended spreader grafts), in patients with persistent deviation of the l-strut after previous septoplasty with limited remaining autologous cartilage for bracing, and in pediatric patients to limit the amount of septal cartilage removed. Reported complications included continued symptomatic nao (n-1) which required revision surgery, a (b)(6)-year-old patient with mild external nasal valve narrowing/collapse and mild internal nasal valve collapse, a (b)(6)-year-old patient with severe right internal nasal valve narrowing which is scheduled for a revision surgery, a (b)(6)-year-old patient with severe right internal nasal valve collapse, and a (b)(6)-year-old patient with moderate dorsal septal deviation, moderate left internal nasal valve narrowing, and severe inferior turbinate hypertrophy. It was concluded that pds plates are safe and effective absorbable material for stabilizing and straightening fractures or severe deviations of the cartilaginous l-strut. There is long-term stability of the clinically and statistically significant improvements in nasal obstruction following functional septorhinoplasty with 0. 25-mm pds beyond the time it takes the plate to resorb. The use of pds plates may also decrease the need for rib grafting in patients with l-strut compromise and a history of previous septoplasty, thereby decreasing patient morbidity and surgical time.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2210968-2018-71922
MDR Report Key7399649
Report SourceLITERATURE
Date Received2018-04-05
Date of Report2018-03-16
Date Mfgr Received2018-03-16
Date Added to Maude2018-04-05
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDARLENE KYLE
Manufacturer StreetP.O. BOX 151, ROUTE 22 WEST
Manufacturer CitySOMERVILLE NJ 088760151
Manufacturer CountryUS
Manufacturer Postal088760151
Manufacturer Phone9082182792
Manufacturer G1ETHICON INC.
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePDS PLATE UNKNOWN PRODUCT
Generic NamePOLYMER, EAR, NOSE AND THROAT, SYNTHETIC, ABSORBABLE
Product CodeNHB
Date Received2018-04-05
Catalog NumberUNK
Lot NumberUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerETHICON INC.
Manufacturer AddressP.O. BOX 151, ROUTE 22 WEST SOMERVILLE NJ 088760151 US 088760151


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-04-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.